India Active Pharmaceutical Ingredients Market, By Manufacturer (Captive AP I and Merchant API), By Synthesis Type (Synthetic and Biotech), By Drug Type (Generic and Branded), By Application (Cardiology, Oncology, Pulmonology, Neurology, Orthopedic, Ophth

India Active Pharmaceutical Ingredients Market, By Manufacturer (Captive AP I and Merchant API), By Synthesis Type (Synthetic and Biotech), By Drug Type (Generic and Branded), By Application (Cardiology, Oncology, Pulmonology, Neurology, Orthopedic, Ophthalmology, and Other), By Product Type (Low Potent APIs and High Potent APIs), By Formulation (Oral, Topical, Parenteral, Drops, and Others)


India has established itself as a global sourcing hub for generic APIs due to availability of large pool of scientifically skilled professionals and a robust manufacturing infrastructure. Lower costs of production and strong process chemistry skills have enabled Indian pharmaceutical companies to gain market share in regulated markets. The country manufactures over 350 APIs across therapeutic areas including anti-retrovirals, anti-infectives, Cardiovascular, Anti-diabetics, and Oncology segments. Rising expenditures on healthcare and increasing demand for generic drugs can drive the market growth.

Market Dynamics:

India active pharmaceutical ingredients market growth is driven by rising availability of affordable treatment options due to a large domestic population base and rapidly growing exports. Strong process chemistry skills and lower costs enjoyed by domestic manufacturers compared to Western counterparts drives the market growth. However, stringent regulatory norms in overseas markets and environmental compliance issues can hamper the market growth. Moreover, dependence on imports for key starting materials limits self-reliance. Development of complex generics and novel drug delivery systems can offer opportunities in specialty/orphan drugs segments. Investments in R&D and upgradation of technological capabilities is crucial for companies to sustain leadership in long run.

Key Features of the Study:
  • This report provides in-depth analysis of the India active pharmaceutical ingredients market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the India active pharmaceutical ingredients market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Sun Pharmaceutical Industries, Lupin, Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • India active pharmaceutical ingredients market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the India active pharmaceutical ingredients market
Detailed Segmentation-
  • By Manufacturer
  • Captive API
  • Merchant API
  • By Synthesis Type
  • Synthetic
  • Biotech
  • By Drug Type
  • Generic
  • Branded
  • By Application
  • Cardiology
  • Oncology
  • Pulmonology
  • Neurology
  • Orthopedic
  • Ophthalmology
  • Other
  • By Product Type
  • Low Potent APIs
  • High Potent APIs
  • By Formulation
  • Oral
  • Topical
  • Parenteral
  • Drops
  • Others
  • Company Profiles:
  • Reddy's Laboratories
  • Aurobindo Pharma
  • Lupin
  • Cipla
  • Sun Pharmaceutical Industries
  • Cadila Healthcare
  • Hetero Drugs
  • Divis Laboratories
  • Jubilant Pharmova
  • Granules India
  • Laurus Labs
  • Aarti Drugs
  • Alembic Pharmaceuticals
  • Alkem Laboratories
  • Biocon
  • Glenmark Pharmaceuticals
  • Ipca Laboratories
  • Unichem Laboratories


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Application
Market Snapshot, By Sample Type
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Chemiluminescence Immunoassay Market- Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Chemiluminescence Immunoassay Market, By Product Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Analyzers
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Automated
Semi-automated
Reagents
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Luminophore Markers
Enzymatic Markers
Consumables
6. Global Chemiluminescence Immunoassay Market, By Application, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Therapeutic Drug Monitoring
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Oncology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Endocrinology
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Infectious Disease
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Autoimmune Disease
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Chemiluminescence Immunoassay Market, By Sample Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Blood
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Urine
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Saliva
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Other Sample Types
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Chemiluminescence Immunoassay Market, By End User, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Hospitals
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Clinical Laboratories
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Pharmaceutical and Biotechnology Companies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
9. Global Chemiluminescence Immunoassay Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2020–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Sample Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
Siemens AG
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Abbott Laboratories
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
F. Hoffmann-La Roche Ltd.
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Danaher Corporation
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
bioMérieux SA
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Johnson & Johnson
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Tosoh Corporation
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
Randox Laboratories
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
DiaSorin S.p.A.
Company Highlights
Method Portfolio
Key Highlights
Financial Performance
Market Strategies
PerkinElmer, Inc.
Mindray Bio-Medical Electronics Co., Ltd.
Getein Biotech, Inc.
QuidelOrtho Corporation
Sysmex Corporation
Ortho Clinical Diagnostics
Abcam plc
Thermo Fisher Scientific Inc.
Hologic, Inc.
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 28 figures on “Chemiluminescence Immunoassay Market” -Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings